Pharma Pressreleases

This section covers the managerial aspects in the Pharma industry.

Backed by Science and Proven Results, TCI Is Integrating Nutraceutical and Cosmeceutical Actives for Brands

Friday, September 30, 2016
PR Newswire

TAIPEI Taiwan Sept 30 2016 PRNewswire Over the past few years the demand for health and antiaging nutraceutical and cosmeceutical products has grown dramatically due mainly to the rise in the elderly population around the world and the increase in healthconscious consumers Without a doubt people a..

Reinventing Healthcare: Singularity University\'s Exponential Medicine Returns to San Diego October 8-11

Friday, September 30, 2016
PR Newswire

MOFFETT FIELD Calif Sept 30 2016 PRNewswire Singularity University SU is bringing together over 500 global leaders in technology and healthcare for its sixth annual Exponential Medicine Conference October 811 2016 at the Hotel del Coronado in San Diego California The conference will explore the cu..

Biotechs and the Advancements in Cancer Oriented Clinical Trials

Friday, September 30, 2016
PR Newswire

NEW YORK September 30 2016 PRNewswire An important step in discovering new treatments for cancer and any sort of disease as well as new ways to identify analyze and decrease the risk of disease is by performing clinical trials This shows researchers the many approaches we are capable of and whil..

Supported by the UAE Ministry of Health and Prevention Dubai hosts the 3rd GCC Pharmacy Congress

Friday, September 30, 2016

Under the supportof the UAE Ministry of Health and Prevention Dubai hosts the 3rd GCC Pharmacy Congress this October 2016 which is also supported by the Executive Board HealthMinisters Council for Cooperation Council States Saudi Arabia the American College of Clinical Pharmacy ACCP Bahrain Medical ..

Miami Children’s Health System Expands Relationship With Cerner

Friday, September 30, 2016
GLOBE NEWSWIRE

MIAMI Sept 30 2016 GLOBE NEWSWIRE Miami Childrens Health System MCHS and its affiliates Pediatric Specialists of America and Nicklaus Childrens Hospital have expanded their relationship with Cerner a global leader in health care technology Through its Business Office Services BOS offering Cern..

Emergent BioSolutions Provides Update on Status of BioThrax Procurement Contract and Discussions With CDC

Friday, September 30, 2016
GLOBE NEWSWIRE

GAITHERSBURG Md Sept 30 2016 GLOBE NEWSWIRE Emergent BioSolutions Inc NYSEEBS today provided an update on the status of its 2011 BioThrax Anthrax Vaccine Adsorbed procurement contract and the status of its discussions with the Centers for Disease Control and Prevention CDC for a followon procu..

EmblemHealth and LaborPress Honor Heroic Actions of Union Members

Friday, September 30, 2016
GLOBE NEWSWIRE

NEW YORK Sept 30 2016 GLOBE NEWSWIRE Last night EmblemHealth and LaborPress honored the achievements of courageous union members at the fifth annual Heroes of Labor Awards Representing seven different New York City Labor unions this years honorees included ten individuals who took action to sa..

Braeburn Pharmaceuticals and Camurus Enroll First Patients in a Phase 3 Efficacy Trial of CAM2038 for Treatment of Chronic Low Back Pain

Friday, September 30, 2016
PR Newswire

PRINCETON NJ and LUND Sweden Sept 30 2016 PRNewswire Braeburn Pharmaceuticals and Camurus announce that the first patients have been enrolled in the randomized doubleblind placebocontrolled Phase 3 efficacy and safety trial of CAM2038 in patients with moderate to severe chronic low back pain that..

Sinovac Schedules 2016 Annual Meeting of Shareholders

Friday, September 30, 2016
PR Newswire

BEIJING Sept 30 2016 PRNewswire Sinovac Biotech Ltd NASDAQ SVA a leading provider of biopharmaceutical products in China announced today that it will hold its 2016 Annual Meeting of Shareholders on Monday November 7 2016 at 900 am Beijing Time The meeting will be held at No 39 Shangdi Xi Road Hai..

OncoSec to Host Fourth Quarter and Fiscal Year End Financial Results Conference Call on October 13, 2016

Friday, September 30, 2016
PR Newswire

SAN DIEGO Sept 30 2016 PRNewswire OncoSec Medical Incorporated OncoSec NASDAQ ONCS a company developing DNAbased intratumoral cancer immunotherapies today announced that the Company will host its fiscal fourth quarter and fiscal year end 2016 financial results conference call on Thursday October 1..

BD Expands Efforts To Combat Antimicrobial Resistance With New Automated ID/AST System

Friday, September 30, 2016
PR Newswire

FRANKLIN LAKES NJ Sept 30 2016 PRNewswire BD Becton Dickinson and Company NYSE BDX a leading global medical technology company today announced the launch of its next generation diagnostic instrument for the rapid identification of bacteria and detection of antimicrobial resistance The global heal..

BioDelivery Sciences Cites Impressive Number of Physicians Granted Waiver to Increase Patient Limit for Opioid Dependence Treatment Following Recent HHS Rule

Friday, September 30, 2016
PR Newswire

RALEIGH NC Sept 30 2016 PRNewswire BioDelivery Sciences International Inc NASDAQ BDSI reported that according to the Substance Abuse and Mental Health Services Administration SAMHSA 1665 clinicians have applied for and were granted waivers to prescribe buprenorphine for the treatment of opioid de..

Regeneron Announces Phase 2 Study of Aflibercept Co-Formulated with Rinucumab (anti-PDGFR-beta) Shows No Benefit Over Aflibercept Alone in Neovascular Age-Related Macular Degeneration

Friday, September 30, 2016
PR Newswire

TARRYTOWN NY Sept 30 2016 PRNewswire Regeneron Pharmaceuticals Inc NASDAQ REGN today announced topline results from the Phase 2 CAPELLA study evaluating aflibercept coformulated with rinucumab an antiplateletderived growth factor receptor beta antiPDGFRbeta antibody in patients with neovascular a..

Endo Pharmaceuticals Presents New Phase 2 Data Evaluating the Safety and Effectiveness of XIAFLEX® (Collagenase Clostridium Histolyticum) for Dupuytren\'s Disease Nodules

Friday, September 30, 2016
PR Newswire

Study Participants in the Higher Dose Groups Treated with a Single Injection of XIAFLEX Showed Statistically Significant Decrease in Size and Hardness of Dupuytrens Disease Nodules a PreCursor Condition to Dupuytrens Contracture DUBLIN Sept 30 2016 PRNewswire Endo Pharmaceuticals Inc a subsidi..

More than 600 Astellas employees to give back to local communities across the U.S. and Brazil for Changing Tomorrow Day - the company\'s 7th annual global day of service

Friday, September 30, 2016
PR Newswire

NORTHBROOK Ill Sept 30 2016 PRNewswire Today more than 600 Astellas employees on two continents will get out of their offices roll up their sleeves and help their communities This will be done in support of Changing Tomorrow Day CTDay16 a global effort to contribute time and resources to building..

AbbVie\'s Investigational HCV Regimen Receives U.S. FDA Breakthrough Therapy Designation

Friday, September 30, 2016
PR Newswire

NORTH CHICAGO Ill Sept 30 2016 PRNewswire AbbVie NYSE ABBV a global biopharmaceutical company today announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation BTD for the investigational pangenotypic regimen of glecaprevir ABT493pibrentasvir ABT530 GP for t..

\"The Science Behind Logistics\" Webinar, Hosted by Cryoport

Friday, September 30, 2016
PR Newswire

IRVINE Calif Sept30 2016 PRNewswire Cryoport Inc NASDAQ CYRX CYRXW Company the worlds leading cryogenic logistics company announced today that Dr Mark Sawicki Chief Commercial Officer is scheduled to present a webinar titled The Science Behind Logistics discussing how new therapeutic products requ..

Tocagen to Present Clinical and Preclinical Data at Two Scientific Meetings

Friday, September 30, 2016
PR Newswire

SAN DIEGO Sept 30 2016 PRNewswire Tocagen Inc a clinicalstage cancerselective gene therapy company today announced clinical and preclinical data involving Toca 511 Toca FC for the treatment of recurrent high grade glioma will be presented at the 10th International Oncolytic Virus Meeting to be h..

Health Canada Approves First Teligent Topical Product

Friday, September 30, 2016
PR Newswire

BUENA NJ Sept 30 2016 PRNewswire Teligent Inc NASDAQ TLGT a New Jerseybased specialty generic pharmaceutical company today announced that its Estonian subsidiary Teligent O has received approval from Health Canadas Therapeutic Products Directorate for Lidocaine Hydrochloride Topical Solution USP T..

OWC Pharmaceutical Research Corp Signs Agreement With US Partner for Funding in Advance of Future Royalties

Friday, September 30, 2016
PR Newswire

PETACH TIKVA Israel September 30 2016 PRNewswire OWC Pharmaceutical Research Corp OTCQB OWCP OWC or the Company an Israelibased developer of cannabinoidbased therapies targeting a variety of different medical conditions and disorders today announced it signed an agreement for 300000 with Medmar ..

TOP